UK clinical trial into puberty blockers on hold after medicines regulator steps in
Posted:
A clinical trial into puberty blockers for children has been paused after the medicines regulator warned it should have a minimum age limit of 14 because of the “unquantified risk” of “long-term biological harms”.
GIANT Health is delighted to welcome XR Therapeutics to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where they will showcase how immersive technology is helping transform mental health care across the NHS.
Mental health services…
GIANT Health is pleased to welcome Psyomics to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where they will showcase their innovative approach to improving mental health services through better information, earlier understanding and more informed…